Company Overview of Ardelyx, Inc.
Key Executives for Ardelyx, Inc.
|Michael G. Raab||30 Relationships||Chief Executive Officer, President and Director||52|
|Mark E. Kaufmann MBA||5 Relationships||CFO & Treasurer||49|
|Reginald Seeto M.D., MBBS||13 Relationships||Chief Operating Officer and Executive Vice President||45|
|Robert C. Blanks MS, RAC||No Relationships||Senior Vice President of Regulatory Affairs and Quality Assurance||--|
|Jeremy S. Caldwell Ph.D.||5 Relationships||Chief Scientific Officer and Executive Vice President||48|
|View More Key Executives|
Ardelyx, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|David M. Mott||206 Relationships||Mersana Therapeutics, Inc.||51|
|Michael G. Raab||30 Relationships||Ardelyx, Inc.||52|
|Richard J. Rodgers||23 Relationships||Ardelyx, Inc.||50|
|Gordon Ringold Ph.D.||55 Relationships||Alavita Pharmaceuticals Inc.||66|
|Annalisa Mary Jenkins MBBS, FRCP||91 Relationships||Dimension Therapeutics, Inc.||52|
Ardelyx, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Richard J. Rodgers||23 Relationships||3 Executives|
|Compensation Committee||David M. Mott||206 Relationships||4 Executives|
|Nominating Committee Ph.D.||Gordon Ringold||55 Relationships||3 Executives|
|Corporate Governance Committee Ph.D.||Gordon Ringold||55 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$5.2M|
|Total Value of Options||$520.0K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.